Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes (PREDICTIVE™)

NCT00504673 Phase 3 COMPLETED

This trial is conducted in Europe. The purpose of the trial is to investigate the effect of insulin detemir on weight change in overweight and obese patients with type 2 diabetes.

Details

Lead sponsor	Novo Nordisk A/S
Phase	Phase 3
Status	COMPLETED
Enrolment	277
Start date	2005-04
Completion	2006-12

Conditions

• Diabetes
• Diabetes Mellitus, Type 2

Interventions

• insulin detemir
• insulin NPH
• insulin aspart

Primary outcomes

• Body weight loss — after 26 weeks of treatment

Countries

Spain